Streptomyces aureofaciens Duggar (ATCC® 12749)

Strain Designations: S1308-29  /  Type Strain: no  /  Biosafety Level: 1

Strain Designations S1308-29
Application
Produces 6-demethyltetracycline
Produces 7-chloro-5a (11a)-dehydrotetracycline
Produces 7-chloro-t-demethyltetracycline
Produces alpha(11 alpha)-dehydrotetracyclines
Produces chlortetracycline aureomycin
Produces tetracycline
Produces tetracyclines
Type Strain no
Biosafety Level 1
Product Format freeze-dried
Preceptrol® no
Type Strain no
Medium Medium 196: Yeast malt extract agar
Growth Conditions
Temperature: 26.0°C
Name of Depositor Lederle Labs.
References

Miller PA, McCormick JR. Biological transformation of anhydrotetracycline to 5alpha(11alpha)-dehydrotetracyclines. US Patent 2,952,587 dated Sep 13 1960

McCormick JR, et al. Process of producing an antibiotic of the tetracycline series. US Patent 2,970,947 dated Feb 7 1961

Miller PA, Growich JA Jr.. New tetracyclines produced by Streptomyces aureofaciens. US Patent 3,007,965 dated Nov 7 1961

McCormick JR, et al. Production of tetracyclines. US Patent 2,998,352 dated Aug 29 1961